Market Stimulus and Genomic Justice: Evaluating the Effects of Market Access to Human Germ-Line Enhancement
Kennedy Institute of Ethics Journal 20 (2):161-179 (2010)
| Abstract | In the debates surrounding the ethical dimensions of interventions in the human genome, much attention is paid to determining whether—and if so, how—market access to these technologies ought to be managed in order to maximize social benefit. There are those who advocate a “laissez-faire” free-market approach to the development and use of genetic and genomic interventions. We are sympathetic to this view insofar as we understand the workings of the market stimulus effect. We use the term “market stimulus effect” to refer to the outcome of a set of mechanisms whereby early adoption of a new technology by wealthy consumers promotes the development of versions of this product that are cheaper to produce, or are simply .. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,875 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesFritz Allhoff (2005). Germ-Line Genetic Enhancement and Rawlsian Primary Goods. Kennedy Institute of Ethics Journal 15 (1):39-56.
Edward B. Flowers (1998). The Ethics and Economics of Patenting the Human Genome. Journal of Business Ethics 17 (15):1737-1745.
Maxwell J. Mehlman (2005). Genetic Enhancement: Plan Now to Act Later. Kennedy Institute of Ethics Journal 15 (1):77-82.
P. H. Sedgwick (1999). The Market Economy and Christian Ethics. Cambridge University Press.
Alistair MacLeod (2000). Human Dignity, Individual Liberty, And the Free Market Ideal. Social Philosophy Today 16:113-123.
James Stacey Taylor (2006). Why the 'Black Market' Arguments Against Legalizing Organ Sales Fail. Res Publica 12 (2).
T. Phillips (2011). From the Ideal Market to the Ideal Clinic: Constructing a Normative Standard of Fairness for Human Subjects Research. Journal of Medicine and Philosophy 36 (1):79-106.
J. Robert Loftis (2005). Germ-Line Enhancement of Humans and Nonhumans. Kennedy Institute of Ethics Journal 15 (1):57-76.
John J. Hanafin (2002). Morality and the Market in China: Some Contemporary Views. Business Ethics Quarterly 12 (1):1-18.
G. K. D. Crozier Christopher Hajzler (2010). Market Stimulus and Genomic Justice: Evaluating the Effects of Market Access to Human Germ-Line Enhancement. Kennedy Institute of Ethics Journal 20 (2):pp. 161-179.
Analytics
Monthly downloads |
Added to index2010-08-16Total downloads6 ( #147,054 of 556,837 )Recent downloads (6 months)1 ( #64,847 of 556,837 )How can I increase my downloads? |
My notes
Discussion
